Business Standard

Sunday, December 22, 2024 | 10:32 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

India starts probe after Uzbekistan cough syrup deaths, Noida firm responds

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests

cough syrup, medicine, cold
Premium

File photo of cough syrup. Photo: Shutterstock

Press Trust of India
The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm, official sources said on Thursday.
 
The health ministry of Uzbekistan has claimed that the 18 children had consumed cough syrup, 'Doc-1 Max', manufactured by Noida-based Marion Biotech.
 
Hasan Harris, legal representative of Marion Biotech, said the governments of both countries are looking into the matter and inquiring.
 
"There is no problem from our end and no issue in testing. We have been there for the past ten years.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in